Cochrane review found emerging but inconclusive evidence for early psychosis interventions, including cannabis-specific therapy
A Cochrane review of 18 RCTs (n=1808) found emerging evidence for specialized early intervention services in psychosis but inconclusive results for most specific treatments, including cannabis-focused psychosis therapy.
Quick Facts
What This Study Found
This Cochrane systematic review examined whether early intervention could improve outcomes in psychosis across 18 RCTs with 1,808 participants.
For psychosis prevention in prodromal patients: olanzapine showed little benefit, CBT was similarly inconclusive, risperidone plus CBT showed short-term benefit at 6 months but not 12 months, and omega-3 fatty acids showed a promising but unreplicated result.
For first-episode psychosis treatment: specialized early intervention teams showed some benefit for treatment retention and independent living at 5 years. Phase-specific cannabis and psychosis therapy did not show significant benefit (RR for cannabis use 1.30, CI 0.8-2.2). Vocational intervention improved employment.
The largest and highest quality study showed specialized teams reduced dropout and improved treatment compliance, with better independent living at 5 years but not at 1 year.
Key Numbers
18 RCTs, n=1808. Cannabis-psychosis therapy: RR 1.30 (0.8-2.2), not significant. Specialized teams: reduced dropout RR 0.59 (0.4-0.8), NNT 9. Independent living at 5 years: RR 0.42 (0.21-0.8), NNT 19.
How They Did This
Cochrane systematic review of RCTs for preventing psychosis in prodromal individuals or improving outcomes in first-episode psychosis. 18 RCTs identified (n=1808). Risk ratios with 95% CIs calculated. NNT/NNH computed where possible.
Why This Research Matters
The finding that cannabis-specific psychosis therapy did not show measurable benefit was important for treatment planning, while the broader finding that early intervention services had emerging support informed mental health policy.
The Bigger Picture
This authoritative Cochrane review established the evidence base for early intervention in psychosis as "emerging but inconclusive," influencing service development and research priorities globally.
What This Study Doesn't Tell Us
Studies were diverse, mostly small, and conducted by pioneering researchers with methodological limitations. Meta-analysis was inappropriate for most comparisons. Cannabis-psychosis therapy data came from a single small trial (n=47).
Questions This Raises
- ?Are early intervention gains maintained long-term?
- ?Can cannabis-specific therapy be improved and retested?
- ?What components of specialized early intervention are most effective?
Trust & Context
- Key Stat:
- Cannabis-psychosis specific therapy did not show benefit (n=47)
- Evidence Grade:
- Cochrane systematic review representing the highest standard of evidence synthesis, though noting most included studies were small and methodologically limited.
- Study Age:
- Published in 2011. Early intervention services have expanded significantly since, with more robust evidence emerging.
- Original Title:
- Early intervention for psychosis.
- Published In:
- The Cochrane database of systematic reviews, CD004718 (2011)
- Authors:
- Marshall, Max, Rathbone, John
- Database ID:
- RTHC-00507
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Does early intervention help in psychosis?
This review found emerging but not yet conclusive evidence that specialized early intervention teams improve outcomes, particularly for treatment retention and independent living. Individual specific treatments showed mixed results.
Is there a therapy specifically for cannabis and psychosis?
A cannabis-specific psychosis therapy was tested in one small trial (47 patients) included in this review but did not show significant benefit for reducing cannabis use.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00507APA
Marshall, Max; Rathbone, John. (2011). Early intervention for psychosis.. The Cochrane database of systematic reviews, CD004718. https://doi.org/10.1002/14651858.CD004718.pub3
MLA
Marshall, Max, et al. "Early intervention for psychosis.." The Cochrane database of systematic reviews, 2011. https://doi.org/10.1002/14651858.CD004718.pub3
RethinkTHC
RethinkTHC Research Database. "Early intervention for psychosis." RTHC-00507. Retrieved from https://rethinkthc.com/research/marshall-2011-early-intervention-for-psychosis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.